Invention Grant
- Patent Title: Hormone receptor modulators for treating metabolic conditions and disorders
-
Application No.: US16327791Application Date: 2017-08-23
-
Publication No.: US10793568B2Publication Date: 2020-10-06
- Inventor: Jianhua Chao , Rakesh Jain , Lily Hu , Jason Gustaf Lewis , Helene Baribault , Jeremy Caldwell
- Applicant: ARDELYX, INC.
- Applicant Address: US CA Fremont
- Assignee: ARDELYX, INC.
- Current Assignee: ARDELYX, INC.
- Current Assignee Address: US CA Fremont
- Agency: Viksnins Harris Padys Malen LLP
- International Application: PCT/US2017/048281 WO 20170823
- International Announcement: WO2018/039386 WO 20180301
- Main IPC: C07D471/08
- IPC: C07D471/08 ; C07D493/08 ; C07D413/14 ; C07F9/6558 ; C07D417/14 ; C07D413/12
Abstract:
The invention relates to activators of FXR useful in the treatment of autoimmune disorders, liver disease, intestinal disease, kidney disease, cancer, and other diseases in which FXR plays a role, having the Formula (I): (I), wherein L1, A, X1, X2, R1, R2, and R3 are described herein.
Public/Granted literature
- US20190233420A1 HORMONE RECEPTOR MODULATORS FOR TREATING METABOLIC CONDITIONS AND DISORDERS Public/Granted day:2019-08-01
Information query
